These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 8999800)

  • 1. Requirement for the transcription factor LSIRF/IRF4 for mature B and T lymphocyte function.
    Mittrücker HW; Matsuyama T; Grossman A; Kündig TM; Potter J; Shahinian A; Wakeham A; Patterson B; Ohashi PS; Mak TW
    Science; 1997 Jan; 275(5299):540-3. PubMed ID: 8999800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pillars Article: Requirement for the Transcription Factor LSIRF/IRF4 for Mature B and T Lymphocyte Function.
    Mittrücker HW; Matsuyama T; Grossman A; Kündig TM; Potter J; Shahinian A; Wakeham A; Patterson B; Ohashi PS; Mak TW
    J Immunol; 2017 Dec; 199(11):3717-3720. PubMed ID: 29158347
    [No Abstract]   [Full Text] [Related]  

  • 3. Expression of interferon regulatory factor 4 in chronic myeloid leukemia: correlation with response to interferon alfa therapy.
    Schmidt M; Hochhaus A; König-Merediz SA; Brendel C; Proba J; Hoppe GJ; Wittig B; Ehninger G; Hehlmann R; Neubauer A
    J Clin Oncol; 2000 Oct; 18(19):3331-8. PubMed ID: 11013272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcription factor IRF4 controls plasma cell differentiation and class-switch recombination.
    Klein U; Casola S; Cattoretti G; Shen Q; Lia M; Mo T; Ludwig T; Rajewsky K; Dalla-Favera R
    Nat Immunol; 2006 Jul; 7(7):773-82. PubMed ID: 16767092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcription factor IRF4 regulates germinal center cell formation through a B cell-intrinsic mechanism.
    Willis SN; Good-Jacobson KL; Curtis J; Light A; Tellier J; Shi W; Smyth GK; Tarlinton DM; Belz GT; Corcoran LM; Kallies A; Nutt SL
    J Immunol; 2014 Apr; 192(7):3200-6. PubMed ID: 24591370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fidelity and infidelity in commitment to B-lymphocyte lineage development.
    Rolink AG; Schaniel C; Busslinger M; Nutt SL; Melchers F
    Immunol Rev; 2000 Jun; 175():104-11. PubMed ID: 10933595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stages of germinal center transit are defined by B cell transcription factor coexpression and relative abundance.
    Cattoretti G; Shaknovich R; Smith PM; Jäck HM; Murty VV; Alobeid B
    J Immunol; 2006 Nov; 177(10):6930-9. PubMed ID: 17082608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delayed lymphoid repopulation with defects in IL-4-driven responses produced by inactivation of NF-ATc.
    Ranger AM; Hodge MR; Gravallese EM; Oukka M; Davidson L; Alt FW; de la Brousse FC; Hoey T; Grusby M; Glimcher LH
    Immunity; 1998 Jan; 8(1):125-34. PubMed ID: 9462518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional status of cells from lymphoid and myeloid tissues in mice with severe combined immunodeficiency disease.
    Dorshkind K; Keller GM; Phillips RA; Miller RG; Bosma GC; O'Toole M; Bosma MJ
    J Immunol; 1984 Apr; 132(4):1804-8. PubMed ID: 6607948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced TCR-induced apoptosis in interferon regulatory factor 4-deficient CD4(+) Th cells.
    Lohoff M; Mittrücker HW; Brüstle A; Sommer F; Casper B; Huber M; Ferrick DA; Duncan GS; Mak TW
    J Exp Med; 2004 Jul; 200(2):247-53. PubMed ID: 15249594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ablation of Transcription Factor IRF4 Promotes Transplant Acceptance by Driving Allogenic CD4
    Wu J; Zhang H; Shi X; Xiao X; Fan Y; Minze LJ; Wang J; Ghobrial RM; Xia J; Sciammas R; Li XC; Chen W
    Immunity; 2017 Dec; 47(6):1114-1128.e6. PubMed ID: 29221730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigen presentation and immune regulatory capacity of immature and mature-enriched antigen presenting (dendritic) cells derived from human bone marrow.
    Jin Y; Fuller L; Ciancio G; Burke GW; Tzakis AG; Ricordi C; Miller J; Esquenzai V
    Hum Immunol; 2004 Feb; 65(2):93-103. PubMed ID: 14969764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defective B cell receptor-mediated responses in mice lacking the Ets protein, Spi-B.
    Su GH; Chen HM; Muthusamy N; Garrett-Sinha LA; Baunoch D; Tenen DG; Simon MC
    EMBO J; 1997 Dec; 16(23):7118-29. PubMed ID: 9384589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphocytes lacking I kappa B-alpha develop normally, but have selective defects in proliferation and function.
    Chen CL; Singh N; Yull FE; Strayhorn D; Van Kaer L; Kerr LD
    J Immunol; 2000 Nov; 165(10):5418-27. PubMed ID: 11067893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IRF4 - a factor for class switching and antibody secretion.
    Fillatreau S; Radbruch A
    Nat Immunol; 2006 Jul; 7(7):704-6. PubMed ID: 16785887
    [No Abstract]   [Full Text] [Related]  

  • 16. Interferon regulatory factor 4 regulates thymocyte differentiation by repressing Runx3 expression.
    Cao Y; Li H; Sun Y; Chen X; Liu H; Gao X; Liu X
    Eur J Immunol; 2010 Nov; 40(11):3198-209. PubMed ID: 21061442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual regulation of IRF4 function in T and B cells is required for the coordination of T-B cell interactions and the prevention of autoimmunity.
    Biswas PS; Gupta S; Stirzaker RA; Kumar V; Jessberger R; Lu TT; Bhagat G; Pernis AB
    J Exp Med; 2012 Mar; 209(3):581-96. PubMed ID: 22370718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Demonstration of organ differences in peripheral B cell populations through the use of deficient fetal bovine serum.
    Campbell SM; Kagnoff MF; Watson J
    J Immunol; 1975 Mar; 114(3):992-6. PubMed ID: 803537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development.
    Matsuyama T; Kimura T; Kitagawa M; Pfeffer K; Kawakami T; Watanabe N; Kündig TM; Amakawa R; Kishihara K; Wakeham A
    Cell; 1993 Oct; 75(1):83-97. PubMed ID: 8402903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oct-2 is required early in T cell-independent B cell activation for G1 progression and for proliferation.
    Corcoran LM; Karvelas M
    Immunity; 1994 Nov; 1(8):635-45. PubMed ID: 7600291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.